Welcome and Acknowledgements

Size: px

Start display at page:

Download "Welcome and Acknowledgements"

Veronica Rice
5 years ago
Views:

2 Welcome and Acknowledgements Jeffrey C. Lerner, PhD, President and Chief Executive Officer, ECRI Institute

2015 Annual Conference Organizers AcademyHealth Agency for Healthcare Research and Quality Bipartisan Policy Center Department of Veterans Affairs ECRI Institute Health Affairs Jayne Koskinas Ted

3 2015 Annual Conference Organizers AcademyHealth Agency for Healthcare Research and Quality Bipartisan Policy Center Department of Veterans Affairs ECRI Institute Health Affairs Jayne Koskinas Ted Giovanis Foundation for Health and Policy Kaiser Permanente Leonard Davis Institute of Health Economics National Cancer Institute Patient-Centered Outcomes Research Institute University of Pennsylvania Health System

4 About ECRI Institute ECRI Institute is a nonprofit organization that has researched the best approaches to patient care nearly 50 years.

5 About ECRI Institute Over 5,000 providers, public and private payers, government agencies, ministries of health, voluntary sector organizations, associations, and accrediting agencies worldwide rely on ECRI Institute's expertise in:

6 About ECRI Institute

7 ECRI Institute s Conflict of Interest Policy ECRI Institute does not accept gifts, grants, or consulting contracts from the medical device or pharmaceutical industries, and accepts no advertising. Federal income tax returns for all employees are examined yearly to ensure there are no investments in these industries.

8 22 Years of Conferences 2014: The NEW Complex Patient: The Shifting Locus of Care and Cost 2013: Data BIG and Small: What Healthcare Decision Makers are Using Now 2012: Creating "Systemness" within Healthcare Delivery: Can Success Be Proven and Shared? 2011: Patient-Centeredness in Policy and Practice: A Conference on Evidence, Programs, and Implications 2010: Comparative Effectiveness and Personalized Medicine: An Essential Interface 2008: How Effective is Value-Based Purchasing in the Public and Private Sectors? 2007: Comparative Effectiveness of Health Interventions: Strategies to Change Policy and Practice 2006: Confronting the Dilemmas of Risk in Healthcare: Emerging Trends and Practical Approaches 2005: Chronic Pain as a Health System Priority: How Evidence Could Inform Policy and Practice 2004: Preventing and Treating Overweight and Obesity: How Effective Are the Interventions? 2003: From Populations to Persons: Putting Evidence-based Medicine Research into Practice 2002: Making Coverage Decisions: Employment-based Coverage, Federal/State and State-Only Programs, and Medicare Carriers 2001: International Society of Technology Assessment in Health Care 2000: Beyond Medical Error: How the Healthcare Community Accepts New Technology as "Safe. 1999: Conflict and Change: How Quality Enters the Coverage Decision 1998: Evidence-Based Medicine on Trial: The Impact of Health Services Research on Law and Regulation 1997: The Clash over Diagnostic and Screening Technology: Balancing Consumer Needs, Payer and Provider Constraints, and the Public Good 1996: Healthcare Technology Choices under Managed Care: Communicating Directly with Patients and Their Clinicians 1995: Healthcare Coverage Decision Making in the Public and Private Sectors 1994: Assessing Controversial Transplant Technologies: Pancreas Transplantation, Liver Transplantation, ABMT for Breast Cancer 1993: The New Era in Health Technology Assessment for Payers, Providers, and Manufacturers

9 SPEAKER BIOS Visit the conference website to view the bios of our speakers. ly.ecri.org/ecri15

10 IMPORTANT NOTICE We have asked all of today s speakers to express their personal views, where appropriate. Their doing so will provide all of us with a far richer intellectual experience. If you wish to quote or paraphrase their perspectives outside of the conference venue, please be certain to obtain their permission and clarify which statements represent official policy and which are personal viewpoints. Your cooperation will help preserve the ECRI Institute conference as an open forum.

11 PRINCIPAL CONTRIBUTORS TO THE CONFERENCE PLANNING Robert Crane ECRI Institute Board of Trustees Gurvaneet Randhawa, MD Agency for Healthcare Research and Quality Christine Cassel, MD National Quality Forum Ann Geiger, MPH, Ph.D. National Cancer Institute Jane Reese-Coulbourne, MS, ChE Reagan Udall Foundation Larry Norton, MD Memorial Sloane-Kettering Cancer Center Jeffrey Shuren, MD, JD Center for Devices and Radiological Health, FDA Patrick Conway, MD, MSc Center for Medicare and Medicaid Services Larry Kaiser, MD Temple University Health System Susan Freeman, MD, MS Temple University Health System Janet Marchibroda Bipartisan Policy Center Marian James, MA, Ph.D. Agency for Healthcare Research and Quality Carolyn Clancy, MD Department of Veterans Affairs David Atkins, MD, MPH Department of Veterans Affairs Jean Slutsky, PA, MSPH Patient Centered Outcomes Research Institute Norbert Goldfield, MD The Journal of Ambulatory Management Richard Schilsky, MD, FACP, FASCO American Society of Clinical Oncologists Ted Giovanis Jayne Koskinas Ted Giovanis Foundation for Health and Policy Joe Selby, MD Patient Centered Outcomes Research Institute Lisa Simpson, MB, B.CH, MPH, FAAP AcademyHealth Murray Ross, Ph.D. Kaiser Permanente Institute for Health Policy Ralph Muller University of Pennsylvania Health Systems Rene Rothstein-Rubin, MD Rittenhouse Hematology and Oncology

12 SPECIAL ACKNOWLEDGEMENTS Dan Leonard National Pharmaceutical Council Robert Dubois, MD, PhD National Pharmaceutical Council Richard Ricciardi, PhD, NP Agency for Healthcare Research and Quality Kristie Kiser Agency for Healthcare Research and Quality Alison Hunt Agency for Healthcare Research and Quality Stephanie Chang Agency for Healthcare Research and Quality Farah Englert Agency for Healthcare Research and Quality Justin Bekelman, MD University of Pennsylvania Health System Tina Grande Healthcare Leadership Council Emily Wilson American Society for Therapeutic Radiology and Oncology Anne Hubbard American Society for Therapeutic Radiology and Oncology Andy Carter Hospital and Healthsystem Association of Pennsylvania Steve Ubl Past CEO, AdvaMed Richard Umbdenstock, MS, FACHE American Hospital Association Richard Pollack, MPA American Hospital Association Marilyn Tavenner, MHA America s Health Insurance Plans Fawn Lopez Modern Healthcare Steven Stack MD American Medical Association

13 ECRI INSTITUTE AND NATIONAL CANCER INSTITUTE CONFERENCE PLANNING COMMITTEE Kristin Finger Tara Kolb Judith Kozloff Evan LeGault Kate McNeill Laurie Menyo Benjamin Pauldine Katie Senycz Russell Turco Stacey Turnbull

14 CONTINUING EDUCATION CREDITS AMA Credit Designation Statement ECRI Institute designates this live activity for a maximum of AMA PRA Category 1 Credit(s)tm. Physicians should claim only the credit commensurate with the extent of their participation in the activity. (6.25 for Day 1 and 4.0 for Day 2) California Nursing Contact Hours This activity has been approved for a total of 12 California State Nursing contact hours by the provider, Debora Simmons, who is approved by the California Board of Registered Nursing, Provider Number CEP (7.5 for Day 1 and 4.5 for Day 2) Pennsylvania CLE Credits This program has been approved by the Supreme Court of Pennsylvania s Continuing Legal Education Board for up to a total of 10.5 substantive credits. Certified Public Health Credits Certified in Public Health (CPH) credits are awarded for attendance in the Cancer Care Delivery in a Rapidly Changing Healthcare System conference, located in Washington, DC on November 17 November 18. You may allot 1 credit per 1 hour of participation, up to 8 credits per day. Instructions for obtaining credits can be found in the CME/CLE/CEU handout that is available at the registration desk.

15 NO-SOLICITATION POLICY ECRI Institute has a no-solicitation policy covering our Annual Conference. In order to provide a distraction-free environment for our attendees, speakers, and sponsors and employees, and to comply with CME requirements, we do not allow solicitation at our conference by attendees or unauthorized parties without the express written permission of ECRI Institute. This policy includes, but is not limited to the following unauthorized activities: Unauthorized receptions & parties (including off-site events) Unauthorized exhibits, mobile exhibits & hospitality suites Unauthorized membership or employment recruitment activities Unauthorized promotion of non-ecri Institute events Unwelcome advances toward event participants or the ECRI Institute staff Unauthorized on-site distribution of printed or electronic materials including literature, signs, flyers, invitations, tickets, forms, etc. (except business cards) Any person and/or organization found to be violating this policy may be expelled from the event. Egregious and/or multiple violations of this policy may result in disqualification from future events at the discretion of ECRI Institute.

16 We thank our speakers for contributing their intellectual efforts. There is no commercial sponsorship for this conference, and the speakers are not paid honoraria. We thank you, the participants in the audience, and we look forward to your questions and to your continuing contributions toward a better healthcare system.

17 IN DEDICATION John Eisenberg Jessie Gruman Ruth Kirschtein Jayne Koskinas Robert Larsen Carol R. Lerner Arthur Malin Norrine Ross Howard Simpson Mary Alice Simpson

18 IN DEDICATION Anita Campbell Bryan Crocker Charlotte Davis Debbie Keating Don Schuler Erin Levitas Jean Menyo Lara Wong Leslie Taichman Nancy Archambeau Pamela Murray Phyllis Torda Robert "Bobby" Bonds Robert Bons Theresa Turnbull Virginia Hudson Virginia Kolesar Virginia Pinkett William Meyer Elizabeth Hunt

19 Session 9 Capstone Session: perspectives on what we have learned and what we can do. Session 1 Our changing understanding of the biology of cancer. Session 2 What is the status of the technologies of precision medicine? Session 7 CEO perspectives on how their differing health systems deliver care now and are preparing for the future. Session 6 How do various integrated delivery systems provide cancer care? Session 8 Looking to the future: legislative and policy perspectives. Session 3 The complex, intertwined role of patients in research and care. Session 5 How to make paying for value valuable. Session 4 How is quality perceived and measured when cancer is a chronic condition?

Improving Diagnosis in Health Care

WATER SCIENCE AND TECHNOLOGY BOARD Improving Diagnosis in Health Care The IOM Quality Chasm Series Committee Members JOHN R. BALL, MD, JD (Chair) American Society for Clinical Pathology and American College